Surgical Patients
Conditions
Keywords
clinical pharmacist, general surgical ward, RCT, SICU
Brief summary
Patients in the surgery ward are at risk of morbidity and mortality from various types of treatment-related problems (TRPs). The primary aim of this study is to assess the impact of the clinical pharmacist in the identification and management of TRPs in the surgery ward.
Detailed description
Patients were randomly assigned to intervention (n=50) and usual care (n=50) arms. The clinical pharmacist assessed the types, frequencies, and clinical significance of TRPs for all recruited patients at baseline. Patients and treating surgeons in the intervention arm received recommendations concerning the identified TRPs, while the usual care arm did not. The number of TRPs was reevaluated at follow-up.
Interventions
clinical pharmacist intervention
Sponsors
University of Jordan
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
All patients were followed up prospectively for their length of hospital stay, and recommendations concerning each identified TRP were provided to the surgeons responsible for patients in the intervention group. Likewise, patient counseling and encouraging adherence to therapy were provided solely to patients in the intervention group. Patients in the control group received usual care by the surgical team without a coordinated contribution from the clinical pharmacist.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Admission for elective, urgent, or emergency surgery * age 18 years or older * Expected length of stay of 3 days or more in the general surgical ward or the SICU
Exclusion criteria
* Pregnancy, breastfeeding, drug or alcohol abuse, active malignancy, or admission for plastic surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Acceptance rate of clinical pharmacist's recommended interventions | 19-week | (Number of recommendations accepted by surgeons) / (total number of recommendations submitted to surgeons by the clinical pharmacist) \*100 |
| Implementation rate of clinical pharmacist's recommended interventions | 19-week | (Number of recommendations implemented by surgeons and patients) / (total number of recommendations submitted to surgeons and patients by the clinical pharmacist) \*100 |
| The impact of the clinical pharmacist on the identification and management of TRPs in the surgery ward | 19-week | Measured by comparing the means of differences in the number of TRPs identified at baseline and at the time of short-term follow-up in the intervention and usual care groups |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Surgeons' attitudes and satisfaction towards the provided clinical pharmacy services | 19-week | Measured by a self-administered questionnaire |
Countries
Jordan
Outcome results
None listed